1. Home
  2. NSSC vs VCEL Comparison

NSSC vs VCEL Comparison

Compare NSSC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$36.91

Market Cap

1.6B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$39.09

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
VCEL
Founded
1969
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
NSSC
VCEL
Price
$36.91
$39.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$48.17
$57.75
AVG Volume (30 Days)
379.4K
530.3K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
60.00
EPS
0.70
N/A
Revenue
$181,621,000.00
$276,259,000.00
Revenue This Year
$13.63
$19.40
Revenue Next Year
$10.05
$18.24
P/E Ratio
$53.56
N/A
Revenue Growth
N/A
16.45
52 Week Low
$26.44
$28.95
52 Week High
$47.61
$43.57

Technical Indicators

Market Signals
Indicator
NSSC
VCEL
Relative Strength Index (RSI) 46.92 66.28
Support Level $34.77 $32.47
Resistance Level $44.43 $42.04
Average True Range (ATR) 1.16 1.57
MACD 0.43 0.39
Stochastic Oscillator 63.10 94.86

Price Performance

Historical Comparison
NSSC
VCEL

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: